| Date Filed | Type | Description |
| 03/01/2023 |
4
| Meek David D. (Director) has filed a Form 4 on uniQure N.V.|
Txns:
| Sold 389 shares
@ $19.71, valued at
$7.7k
|
|
| 01/24/2023 |
4
| Meek David D. (CEO) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 89,379 shares
@ $0
Granted 151,233 options to buy
@ $45.66, valued at
$6.9M
|
|
| 01/19/2023 |
4
| Meek David D. (CEO) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Sold 3,179 shares
@ $42.3764, valued at
$134.7k
|
|
| 12/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/15/2022 |
4
| Meek David D. (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Disposed/sold 15,000 options to buy
@ $6.12, valued at
$91.8k
Granted 11,538 options to buy
@ $2.44, valued at
$28.2k
Disposed/sold 7,500 options to buy
@ $6.12, valued at
$45.9k
Granted 5,769 options to buy
@ $2.44, valued at
$14.1k
|
|
| 01/19/2022 |
4
| Meek David D. (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Granted 27,500 shares
@ $0 |
|
| 01/18/2022 |
4
| Meek David D. (CEO) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 34,057 shares
@ $0
Granted 56,433 options to buy
@ $124.31, valued at
$7M
|
|
| 09/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/24/2021 |
3
| Meek David D. (CEO) has filed a Form 3 on Mirati Therapeutics, Inc. |
| 04/02/2021 |
4
| Meek David D. (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Granted 22,000 shares
@ $0 |
|
| 03/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2019 |
4
| Meek David D. (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Granted 7,500 options to buy
@ $6.12, valued at
$45.9k
Granted 15,000 options to buy
@ $6.12, valued at
$91.8k
|
|
| 06/21/2019 |
3
| Meek David D. (Director) has filed a Form 3 on Entasis Therapeutics Holdings Inc. |
| 01/29/2019 |
4
| Meek David D. (Director) has filed a Form 4 on uniQure N.V.|
Txns:
| Granted 3,230 shares
@ $0
Granted 5,295 options to buy
@ $31.71, valued at
$167.9k
|
|
| 06/18/2018 |
4
| Meek David D. (Director) has filed a Form 4 on uniQure N.V.|
Txns:
| Granted 10,000 options to buy
@ $35.4, valued at
$354k
|
|
| 06/18/2018 |
3
| Meek David D. (Director) has filed a Form 3 on uniQure N.V. |
| 06/07/2016 |
4
| Meek David D. (EVP and President, Oncology) has filed a Form 4 on Baxalta Inc|
Txns:
| Disposed/sold 51,640 shares
@ $0
Disposed/sold 43,334 options to buy
@ $34.29, valued at
$1.5M
Disposed/sold 54,553 options to buy
@ $32.04, valued at
$1.7M
Disposed/sold 6,155 options to buy
@ $31.5, valued at
$193.9k
Disposed/sold 191,421 options to buy
@ $31.5, valued at
$6M
|
|
| 03/07/2016 |
4
| Meek David D. (EVP and President, Oncology) has filed a Form 4 on Baxalta Inc|
Txns:
| Granted 27,976 shares
@ $0
Paid exercise price by delivering 928 shares
@ $39.3, valued at
$36.5k
|
|
| 09/04/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/06/2015 |
4
| Meek David D. (EVP and President, Oncology) has filed a Form 4 on Baxalta Inc|
Txns:
| Acquired 25,068 shares
@ $0
Acquired 43,334 options to buy
@ $34.29, valued at
$1.5M
Acquired 54,553 options to buy
@ $32.04, valued at
$1.7M
Granted 191,421 options to buy
@ $31.5, valued at
$6M
Granted 6,155 options to buy
@ $31.5, valued at
$193.9k
|
|
| 02/10/2014 |
4
| Meek David D. (Chief Commercial Officer) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Granted 7,500 shares
@ $0
Granted 45,000 options to buy
@ $11.11, valued at
$500k
|
|
| 09/16/2013 |
4
| Meek David D. (Chief Commercial Officer) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Sold 10,000 shares
@ $15.5, valued at
$155k
Exercised 10,000 options to buy
@ $8.73, valued at
$87.3k
|
|
| 02/21/2013 |
4
| Meek David D. (Chief Commercial Officer) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Granted 70,000 options to buy
@ $9.86, valued at
$690.2k
|
|
| 08/07/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/07/2012 |
3
| Meek David D. (Chief Commercial Officer) has filed a Form 3 on ENDOCYTE INC |